Emmaus Life Sciences, Inc. (OTCMKTS:EMMA – Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 4,900 shares, a decrease of 51.5% from the February 13th total of 10,100 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 145,500 shares, the days-to-cover ratio is presently 0.0 days.
Emmaus Life Sciences Stock Performance
Shares of OTCMKTS EMMA traded down $0.00 during mid-day trading on Friday, reaching $0.03. 20,578 shares of the company’s stock were exchanged, compared to its average volume of 53,421. The firm has a market capitalization of $1.75 million, a price-to-earnings ratio of -0.30 and a beta of 6.47. Emmaus Life Sciences has a 52-week low of $0.00 and a 52-week high of $0.13. The company’s 50-day moving average is $0.02 and its 200-day moving average is $0.02.
About Emmaus Life Sciences
Featured Stories
- Five stocks we like better than Emmaus Life Sciences
- Expert Stock Trading Psychology Tips
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Find and Profitably Trade Stocks at 52-Week Lows
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Warren Buffett Stocks to Buy Now
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Emmaus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emmaus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.